| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
33,867 |
31,092 |
$2.15M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
34,711 |
31,869 |
$1.49M |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,905 |
1,740 |
$663K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
8,925 |
7,997 |
$520K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,356 |
5,136 |
$357K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
10,561 |
9,885 |
$260K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
660 |
586 |
$237K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,154 |
3,016 |
$209K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14,496 |
13,573 |
$195K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
10,255 |
9,669 |
$162K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,224 |
2,148 |
$161K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
11,031 |
4,989 |
$95K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,601 |
2,403 |
$87K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,847 |
5,357 |
$62K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,932 |
1,799 |
$55K |
| 99050 |
|
3,389 |
3,189 |
$52K |
| 92551 |
|
6,280 |
5,963 |
$48K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,417 |
6,704 |
$47K |
| 99215 |
Prolong outpt/office vis |
375 |
362 |
$35K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
695 |
635 |
$31K |
| 99460 |
|
647 |
593 |
$27K |
| 87428 |
|
537 |
519 |
$21K |
| 87899 |
|
2,380 |
2,148 |
$21K |
| 85018 |
|
9,382 |
8,800 |
$19K |
| 99051 |
|
837 |
797 |
$13K |
| 81002 |
|
4,133 |
3,882 |
$9K |
| 97802 |
|
3,625 |
3,232 |
$8K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
878 |
818 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,275 |
3,506 |
$7K |
| 99462 |
|
367 |
311 |
$7K |
| 99173 |
|
7,193 |
6,608 |
$6K |
| 54150 |
|
37 |
36 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,733 |
2,373 |
$2K |
| 94760 |
|
5,635 |
4,669 |
$546.06 |
| 86308 |
|
76 |
75 |
$314.15 |
| 94667 |
|
26 |
25 |
$311.25 |
| 90670 |
|
5,760 |
5,343 |
$125.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
12 |
12 |
$19.65 |
| 90633 |
|
1,420 |
1,336 |
$0.10 |
| 90710 |
|
1,166 |
1,113 |
$0.00 |
| 90658 |
|
64 |
63 |
$0.00 |
| 90648 |
|
833 |
800 |
$0.00 |
| 90681 |
|
1,032 |
917 |
$0.00 |
| S9441 |
Asthma education, non-physician provider, per session |
1,132 |
966 |
$0.00 |
| 90715 |
|
146 |
137 |
$0.00 |
| 90734 |
|
301 |
286 |
$0.00 |
| 90686 |
|
1,026 |
992 |
$0.00 |
| 90620 |
|
16 |
16 |
$0.00 |
| 90619 |
|
167 |
151 |
$0.00 |
| 90697 |
|
1,094 |
1,010 |
$0.00 |
| 90698 |
|
733 |
680 |
$0.00 |
| 90723 |
|
786 |
753 |
$0.00 |
| 90696 |
|
114 |
112 |
$0.00 |
| 90651 |
|
86 |
82 |
$0.00 |
| 3008F |
|
17 |
14 |
$0.00 |
| 90656 |
|
12 |
12 |
$0.00 |